These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene. Sikes RA; Chung LW Cancer Res; 1992 Jun; 52(11):3174-81. PubMed ID: 1350510 [TBL] [Abstract][Full Text] [Related]
3. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells. Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142 [TBL] [Abstract][Full Text] [Related]
4. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Inoue K; Slaton JW; Eve BY; Kim SJ; Perrotte P; Balbay MD; Yano S; Bar-Eli M; Radinsky R; Pettaway CA; Dinney CP Clin Cancer Res; 2000 May; 6(5):2104-19. PubMed ID: 10815938 [TBL] [Abstract][Full Text] [Related]
5. Reversion of human prostate tumorigenic growth by azatyrosine. Benoit RM; Eiseman J; Jacobs SC; Kyprianou N Urology; 1995 Sep; 46(3):370-7. PubMed ID: 7660512 [TBL] [Abstract][Full Text] [Related]
6. Bone extracellular matrix induces homeobox proteins independent of androgens: possible mechanism for androgen-independent growth in human prostate cancer cells. Robbins SE; Shu WP; Kirschenbaum A; Levine AC; Miniati DN; Liu BC Prostate; 1996 Dec; 29(6):362-70. PubMed ID: 8977633 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. Tan M; Yao J; Yu D Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293 [TBL] [Abstract][Full Text] [Related]
8. Transfer of a dominant-acting tumor-inducing oncogene from human prostatic carcinoma cells to cloned rat embryo fibroblast cells by DNA-transfection. Su ZZ; Olsson CA; Zimmer SG; Fisher PB Anticancer Res; 1992; 12(2):297-304. PubMed ID: 1580547 [TBL] [Abstract][Full Text] [Related]
9. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. Su ZZ; Austin VN; Zimmer SG; Fisher PB Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744 [TBL] [Abstract][Full Text] [Related]
11. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice. Zhang F; Lee J; Lu S; Pettaway CA; Dong Z Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637 [TBL] [Abstract][Full Text] [Related]
12. Metastasis induced by overexpression of p185neu-T after orthotopic injection into a prostatic epithelial cell line (NbE). Marengo SR; Sikes RA; Anezinis P; Chang SM; Chung LW Mol Carcinog; 1997 Jul; 19(3):165-75. PubMed ID: 9254883 [TBL] [Abstract][Full Text] [Related]
13. Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cells. Yu DH; Hung MC Oncogene; 1991 Nov; 6(11):1991-6. PubMed ID: 1682865 [TBL] [Abstract][Full Text] [Related]
14. Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo. Nakashiro K; Kawamata H; Hino S; Uchida D; Miwa Y; Hamano H; Omotehara F; Yoshida H; Sato M Cancer Res; 1998 Feb; 58(3):549-55. PubMed ID: 9458104 [TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and characterization of human FGF8 alternative messenger RNA forms. Ghosh AK; Shankar DB; Shackleford GM; Wu K; T'Ang A; Miller GJ; Zheng J; Roy-Burman P Cell Growth Differ; 1996 Oct; 7(10):1425-34. PubMed ID: 8891346 [TBL] [Abstract][Full Text] [Related]
16. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase. Igawa T; Lin FF; Rao P; Lin MF Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404 [TBL] [Abstract][Full Text] [Related]
17. Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors. Bacus SS; Gudkov AV; Zelnick CR; Chin D; Stern R; Stancovski I; Peles E; Ben-Baruch N; Farbstein H; Lupu R Cancer Res; 1993 Nov; 53(21):5251-61. PubMed ID: 8106145 [TBL] [Abstract][Full Text] [Related]
18. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer. Xia W; Unger P; Miller L; Nelson J; Gelman IH Cancer Res; 2001 Jul; 61(14):5644-51. PubMed ID: 11454719 [TBL] [Abstract][Full Text] [Related]
19. c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Yu D; Wang SS; Dulski KM; Tsai CM; Nicolson GL; Hung MC Cancer Res; 1994 Jun; 54(12):3260-6. PubMed ID: 7911396 [TBL] [Abstract][Full Text] [Related]
20. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Pettaway CA; Pathak S; Greene G; Ramirez E; Wilson MR; Killion JJ; Fidler IJ Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]